These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 11248082)

  • 1. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.
    Borsig L; Wong R; Feramisco J; Nadeau DR; Varki NM; Varki A
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3352-7. PubMed ID: 11248082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications.
    Varki A; Varki NM
    Braz J Med Biol Res; 2001 Jun; 34(6):711-7. PubMed ID: 11378658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans.
    Varki NM; Varki A
    Semin Thromb Hemost; 2002 Feb; 28(1):53-66. PubMed ID: 11885026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis.
    Borsig L; Wong R; Hynes RO; Varki NM; Varki A
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2193-8. PubMed ID: 11854515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.
    Wahrenbrock M; Borsig L; Le D; Varki N; Varki A
    J Clin Invest; 2003 Sep; 112(6):853-62. PubMed ID: 12975470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.
    Kim YJ; Borsig L; Han HL; Varki NM; Varki A
    Am J Pathol; 1999 Aug; 155(2):461-72. PubMed ID: 10433939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome.
    Shao B; Wahrenbrock MG; Yao L; David T; Coughlin SR; Xia L; Varki A; McEver RP
    Blood; 2011 Oct; 118(15):4015-23. PubMed ID: 21860019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects.
    Stevenson JL; Varki A; Borsig L
    Thromb Res; 2007; 120 Suppl 2():S107-11. PubMed ID: 18023703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions.
    Wei M; Tai G; Gao Y; Li N; Huang B; Zhou Y; Hao S; Zeng X
    J Biol Chem; 2004 Jul; 279(28):29202-10. PubMed ID: 15133030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-selectin deficiency attenuates tumor growth and metastasis.
    Kim YJ; Borsig L; Varki NM; Varki A
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9325-30. PubMed ID: 9689079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.
    Borsig L
    Semin Thromb Hemost; 2007 Jul; 33(5):540-6. PubMed ID: 17629852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells.
    Coupland LA; Chong BH; Parish CR
    Cancer Res; 2012 Sep; 72(18):4662-71. PubMed ID: 22836751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low-anticoagulant heparin suppresses metastatic dissemination through the inhibition of tumor cell-platelets association.
    Motta JM; Micheli KVA; Roberto-Fernandes C; Hermsdorff-Brandt M; Guedes AL; Frattani FS; Mourão PAS; Pereira MS
    Biomed Pharmacother; 2024 Feb; 171():116108. PubMed ID: 38218079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
    Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
    FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment.
    Gomes AM; Kozlowski EO; Borsig L; Teixeira FC; Vlodavsky I; Pavão MS
    Glycobiology; 2015 Apr; 25(4):386-93. PubMed ID: 25367817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.
    Ludwig RJ; Boehme B; Podda M; Henschler R; Jager E; Tandi C; Boehncke WH; Zollner TM; Kaufmann R; Gille J
    Cancer Res; 2004 Apr; 64(8):2743-50. PubMed ID: 15087389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest.
    Läubli H; Stevenson JL; Varki A; Varki NM; Borsig L
    Cancer Res; 2006 Feb; 66(3):1536-42. PubMed ID: 16452210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment.
    Borsig L; Wang L; Cavalcante MC; Cardilo-Reis L; Ferreira PL; Mourão PA; Esko JD; Pavão MS
    J Biol Chem; 2007 May; 282(20):14984-91. PubMed ID: 17371880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines.
    Monzavi-Karbassi B; Stanley JS; Hennings L; Jousheghany F; Artaud C; Shaaf S; Kieber-Emmons T
    Int J Cancer; 2007 Mar; 120(6):1179-91. PubMed ID: 17154173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis.
    Chen Y; Peng J; Han M; Omar M; Hu D; Ke X; Lu N
    J Drug Target; 2015 May; 23(4):335-46. PubMed ID: 25541466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.